Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS)

Antiviral Research

Volumn 81, Issue 2, 2009, Pages 93-102

  Serafini, S ^a   Fraternale, A ^a   Rossi, L ^a   Casabianca, A ^a   Antonelli, A ^a   Paoletti, M F ^a   Orlandi, C ^a   Pierige F ^a   Sfara, C ^a   Schiavano, G F ^a   Magnani, M ^a  

^a UNIVERSITY OF URBINO   (Italy)

Author keywords

Drug delivery; HIV reservoirs; Loaded erythrocytes; Macrophages; MAIDS

Indexed keywords

ANTIRETROVIRUS AGENT; CLODRONIC ACID; DIDANOSINE; IMMUNOGLOBULIN G; VIRUS DNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; DNA CONTENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGICAL PARAMETERS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REBOUND; RODENT DISEASE; SPLENOMEGALY; VIRUS REPLICATION;

ANIMALS; ANTI-HIV AGENTS; CLODRONIC ACID; DIDANOSINE; DNA, VIRAL; FEMALE; IMMUNOLOGIC FACTORS; LEUKOCYTE REDUCTION PROCEDURES; MACROPHAGES; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; VIRAL LOAD; ZIDOVUDINE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; MUS;

EID: 58149467497     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2008.09.006     Document Type: Article

References (47)

1. Badley A.D., Dockrell D., Simpson M., Schut R., Lynch D.H., Leibson P., and Paya C.V. Macrophage-dependent apoptosis of CD4 + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185 (1997) 55-64
2. Barrera P., Blom A., van Lent P.L., van Bloois L., Beijnen J.H., van Rooijen N., de Waal Malefijt M.C., van de Putte L.B., Storm G., and van den Berg W.B. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum. 43 (2000) 1951-1959
3. Buller R.M., Yetter R.A., Fredrickson T.N., and Morse III H.C. Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J. Virol. 61 (1987) 383-387
4. Casabianca A., Vallanti G., and Magnani M. Competitive PCR for quantification of BM5d proviral DNA in mice with AIDS. J. Clin. Microbiol. 36 (1998) 2371-2374
5. Casabianca A., Orlandi C., Fraternale A., and Magnani M. Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS. J. Clin. Microbiol. 42 (2004) 4361-4364
6. Cervasi B., Paiardini M., Serafini S., Fraternale A., Menotta M., Engram J., Lawson B., Staprans S.I., Piedimonte G., Perno C.F., Silvestri G., and Magnani M. Administration of fludarabine-loaded autologous red blood cells in simian immunodeficiency virus-infected sooty mangabeys depletes pSTAT-1-expressing macrophages and delays the rebound of viremia after suspension of antiretroviral therapy. J. Virol. 80 (2006) 10335-10345
7. Chattopadhyay S.K., Sengupta D.N., Fredrickson T.N., Morse III H.C., and Hartley J.W. Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. J. Virol. 65 (1991) 4232-4241
8. Chun T.W., and Fauci A.S. Latent reservoirs of HIV: obstacles to the eradication of virus. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10958-10961
9. Chun T.W., Stuyver L., Mizell S.B., Ehler L.A., Mican J.A., Baseler M., Lloyd A.L., Nowak M.A., and Fauci A.S. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13193-13197
10. Crowe S.M., and Sonza S. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J. Leukoc. Biol. 68 (2000) 345-350
11. Crowe S., Zhu T., and Muller W.A. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J. Leukoc. Biol. 74 (2003) 635-641
12. Danenberg H.D., Fishbein I., Gao J., Mönkkönen J., Reich R., Gati I., Moerman E., and Golomb G. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation 106 (2002) 599-605
13. Doherty T.M., Morse III H.C., and Coffman R.L. Modulation of specific T cell responses by concurrent infection with Leishmania major and LP-BM5 murine leukemia viruses. Int. Immunol. 7 (1995) 131-138
14. Fleisch H. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 42 (1991) 919-944
15. Frank D.A., Mahajan S., and Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat. Med. 5 (1999) 444-447
16. Fraternale A., Casabianca A., Rossi L., Chiarantini L., Brandi G., Aluigi G., Schiavano G.F., and Magnani M. Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5′-triphosphate. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12 (1996) 164-173
17. Fraternale A., Rossi L., and Magnani M. Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes. Biochim. Biophys. Acta 1291 (1996) 149-154
18. Fraternale A., Tonelli A., Casabianca A., Vallanti G., Chiarantini L., Schiavano G.F., Benatti U., De Flora A., and Magnani M. Role of macrophage protection in the development of murine AIDS. J. Acquir. Immune Defic. Syndr. 21 (1999) 81-89
19. Fraternale A., Casabianca A., Orlandi C., Cerasi A., Chiarantini L., Brandi G., and Magnani M. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. Antiviral Res. 56 (2002) 263-272
20. Fraternale A., Casabianca A., Orlandi C., Chiarantini L., Brandi G., Silvestri G., and Magnani M. Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels. Virology 302 (2002) 354-362
21. Garaci E., Caroleo M.C., Aloe L., Aquaro S., Piacentini M., Costa N., Amendola A., Micera A., Caliò R., Perno C.F., and Levi-Montalcini R. Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 14013-14018
22. Gartner S., Markovits P., Markovitz D.M., Kaplan M.H., Gallo R.C., and Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233 (1986) 215-219
23. Giuliani A.L., Graldi G., Veronesi M., Lorenzini F., Gandini G., Unis L., Previato A., Wiener E., Wickramasinghe S.N., and Berti G. Potentiation of erythroid abnormalities following macrophage depletion in aged rats. Eur. J. Haematol. 78 (2007) 72-81
24. Herbein G., Mahlknecht U., Batliwalla F., Gregersen P., Pappas T., Butler J., O'Brien W.A., and Verdin E. Apoptosis of CD8 + T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 395 (1998) 189-194
25. Khan S.A., McCloskey E.V., Eyres K.S., Nakatsuka K., Sirtori P., Orgee J., Coombes G., and Kanis J.A. Comparison of three intravenous regimens of clodronate in Paget disease of bone. J. Bone Miner. Res. 11 (1996) 178-182
26. Klinman D.M., and Morse III H.C. Characteristics of B cell proliferation and activation in murine AIDS. J. Immunol. 142 (1989) 1144-1149
27. Koyamada N., Sato A., Takayama J., Usuda M., Kawagishi N., Doi H., Fujimori K., and Satomi S. Macrophage depletion prevents anti-graft antibody production and results in long-term survival in xenotransplantation. Transplant. Proc. 37 (2005) 514-515
28. Kulkosky J., and Bray S. HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication. Curr. HIV Res. 4 (2006) 199-208
29. Lanao J.M., Briones E., and Colino C.I. Recent advances in delivery systems for anti-HIV1 therapy. J. Drug Target 15 (2007) 21-36
30. Lehenkari P.P., Kellinsalmi M., Napänkangas J.P., Ylitalo K.V., Mönkkönen J., Rogers M.J., Azhayev A., Väänänen H.K., and Hassinen I.E. Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-containing metabolite. Mol. Pharmacol. 61 (2002) 1255-1262
31. Levi-Montalcini R. The nerve growth factor 35 years later. Science 237 (1987) 1154-1162
32. Magnani M., Rossi L., Brandi G., Schiavano G.F., Montroni M., and Piedimonte G. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6477-6481
33. Magnani M., Casabianca A., Fraternale A., Brandi G., Chiarantini L., Benatti U., Scarfi S., Millo E., and De Flora A. Inhibition of murine AIDS by a new azidothymidine homodinucleotide. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17 (1998) 189-195
34. Magnani M., Balestra E., Fraternale A., Aquaro S., Paiardini M., Cervasi B., Casabianca A., Garaci E., and Perno C.F. Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. J. Leukoc. Biol. 74 (2003) 764-771
35. Mahlknecht U., Deng C., Lu M.C., Greenough T.C., Sullivan J.L., O'Brien W.A., and Herbein G. Resistance to apoptosis in HIV-infected CD4 + T lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence. J. Immunol. 165 (2000) 6437-6446
36. Meunier P.J., Delmas P.D., Eastell R., McClung M.R., Papapoulos S., Rizzoli R., Seeman E., and Wasnich R.D. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin. Ther. 21 (1999) 1025-1044
37. Morse III H.C., Chattopadhyay S.K., Makino M., Fredrickson T.N., Hügin A.W., and Hartley J.W. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6 (1992) 607-621
38. Mosier D.E., Yetter R.A., and Morse III H.C. Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J. Exp. Med. 165 (1987) 1737-1742
39. Olivetta E., and Federico M. HIV-1 Nef protects human-monocyte-derived macrophages from HIV-1-induced apoptosis. Exp. Cell Res. 312 (2006) 890-900
40. Pomerantz R.J. Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1. HIV Clin. Trials 4 (2003) 137-143
41. Rossi L., Serafini S., Antonelli A., Pierigé F., Carnevali A., Battistelli V., Malatesta M., Balestra E., Caliò R., Perno C.F., and Magnani M. Macrophage depletion induced by clodronate-loaded erythrocytes. J. Drug Target 13 (2005) 99-111
42. Sedaghat A.R., Siliciano R.F., and Wilke C.O. Low-level HIV-1 replication and the dynamics of the resting CD4 + T cell reservoir for HIV-1 in the setting of HAART. BMC Infect. Dis. 8 (2008) 2
43. Shehu-Xhilaga M., Tachedjian G., Crowe S.M., and Kedzierska K. Antiretroviral compounds: mechanisms underlying failure of HAART to eradicate HIV-1. Curr. Med. Chem. 12 (2005) 1705-1719
44. Slegers T.P., van der Gaag R., van Rooijen N., van Rij G., and Streilein J.W. Effect of local macrophage depletion on cellular immunity and tolerance evoked by corneal allografts. Curr. Eye Res. 26 (2003) 73-79
45. Tran E.H., Hoekstra K., van Rooijen N., Dijkstra C.D., and Owens T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 161 (1998) 3767-3775
46. van Lent P.L., Holthuysen A.E., van den Bersselaar L.A., van Rooijen N., Joosten L.A., van de Loo F.A., van de Putte L.B., and van den Berg W.B. Phagocytic lining cells determine local expression of inflammation in type II collagen-induced arthritis. Arthritis Rheum. 39 (1996) 1545-1555
47. van Rooijen N., and van Kesteren-Hendrikx E. Clodronate liposomes: perspectives in research and therapeutics. J. Liposome Res. 12 (2002) 81-94